The reform of the high-value medical supplies system has been officially launched.

Pharmaceutical Network September 30, "Economic Reference" reporter was informed that China's national organization of high-value medical supplies centralized procurement officially started, crown stent was identified as the first procurement varieties, procurement results are expected to be formally implemented in January 2021.
, the state organization of medical supplies centralized procurement has been a number of reports.
Beijing Municipal Health Insurance Bureau issued a notice, requiring the national organization of high-value medical supplies (crown bracket class) centralized procurement of historical procurement data and one-year procurement demand data, reported 80% of the procurement demand will be as the agreed procurement volume.
Ningxia Hui Autonomous Region Medical Insurance Bureau, Hubei Province Health Insurance Bureau notice requirements, the region in 2019 all the use of the crown stent more than 500 public and military medical institutions, other public, military medical institutions and medical insurance fixed-point social-run medical institutions voluntarily participate in filling in the report, each unit should not fill in the procurement needs should not be less than the unit filled in the 2019 The total amount of historical procurement of pharmaceutical alloy crown stents, Shanxi Province is expanded to the previous year's use of more than 100 public and military medical institutions, the relevant authorities said that the state organization of medical supplies centralized procurement is a major reform of the centralized procurement system of medical supplies in the past, in order to allow the people to use high-quality supplies products at relatively low prices.
" After two years of work, centralized procurement of drugs has entered the normal, high-value medical supplies in the field of high prices and centralized procurement reform obviously lag behind, if high-value medical supplies do not reform and breakthrough, can not be the overall transformation of the pharmaceutical sector ecology.
"" crown stent mass, the whole people are full of expectations, the central government also attaches great importance to the crown vein stent to break the high-value medical supplies system reform, is of great significance.
" said that from the high-value supplies dosing, the crown bracket dosing is large, and full competition.
this person revealed that, after the early data analysis, the current domestic independent brand heart stent market share has been nearly 70%.
addition, in a discussion with well-known domestic cardiovascular experts, experts generally believe that the quality of domestic independent brand products has reached or close to the level of foreign brands, with foreign imported brands in the same competition conditions.
, as the first variety of China's national harvest is also more appropriate.
data show that the national medical supplies market size of 320 billion yuan, of which 150 billion yuan of high-value supplies.
from the coronary stent, from 2009 to 2019, China's coronary heart disease interventional treatment developed rapidly, the number of cases per year from 230,000 to more than 1 million cases, an annual growth rate of 10%-20%.
, the number of surgical stents used is about 1.5, which is basically the same level as abroad.
, it is calculated that in 2019 the country will use about 1.5 million crown brackets, the cost of about 15 billion yuan, accounting for one-tenth of the total cost of high-value consumables in the country.
the above-mentioned people, the national organization of the crown bracket centralized belt procurement work in accordance with the national organization, alliance procurement, platform operation of the organizational form and overall thinking.
is a national organization.
is to formulate basic policies, scope and requirements, and to organize the provinces of the country to form alliances.
second is alliance procurement.
Public medical institutions in all provinces (autonomous regions, municipalities directly under the Central Government) and Xinjiang Production and Construction Corps are centralized procurement entities, forming procurement alliances, and members of procurement alliances have appointed representatives to form joint procurement offices to pool demand and strength and improve bargaining power.
is platform operation.
is the Alliance region commissioned Tianjin Pharmaceutical Procurement Center and its supplies procurement platform, to undertake specific centralized procurement work, improve the professional ability and level of centralized procurement.
From the point of view of recruitment rules, the above-mentioned people revealed that the consumables belt procurement rules and drug national procurement similar, in accordance with a certain proportion of total demand for strip procurement, from the rule design will minimize the "recruitment without picking, picking without use" phenomenon.
Enterprise selection method, will be the first price sorting, that is, the enterprise according to the registration certificate declaration and quotation, all quotations from low to high sorting;
symposium held by the Central Committee of the Communist Party of China on the centralized procurement of pharmaceuticals and high-value medical supplies clearly pointed out that the normal institutionalization of drug collection and collection work of state organizations should be promoted.
, to speed up the expansion of the scope of collection, efforts to crack the medical supplies standards are not the same, classification is not clear and other issues, a solid job of heart stent concentration with volume procurement work.
The state-owned enterprises are also generally willing to participate, the aforementioned person said, the State Health Insurance Bureau and Tianjin Municipal Health Insurance Bureau has organized a number of heart stent production enterprises symposium and policy communication meetings, business representatives have said that the country's determination to promote the reform of the recruitment system, the results of the three drug countries and the new situation of the normal procurement of volume has been fully understood and understood.
in particular, some foreign import brand enterprises said that they attach great importance to the national organization's volume procurement, actively cooperate with the joint procurement work, timely application to the global headquarters of enterprises for a larger reduction in the bid price.
domestic independent brand enterprises also said that they will keep the bottom line of product quality, come up with the latest products to participate in bidding, to ensure that the product supply guarantee after the election.
fact, since 2019, Jiangsu and Shanxi, as pilot provinces, have taken the lead in the procurement of crown-pulse brackets.
the "hug group cut price", Shanxi Province selected products the highest decline of 69.12 percent, the lowest decline of 40.2 percent, an average decline of 52.98 percent.
the average price of selected varieties in jiangsu province was 51.01 percent, with the largest decrease of 66.07 percent.
, Lanfan Medical said on the interactive platform, from the company's successful bid in Shanxi Province experience, in the remodeling of the channel value system, the expected sales costs and market costs will be reduced.
the essence of national volume procurement is to compress the intermediate circulation link, for manufacturers will not only reduce the market and sales costs, but also promote the further growth of head enterprises.
overall expectations are more optimistic, the company is also actively preparing for the national crown bracket centralized procurement.
background, a number of industry insiders predict that the national volume procurement, China's coronary heart disease patients surgery supplies costs will plummet.
on the one hand, the intensity of negotiations will be higher than the pilot provinces, on the other hand, from the implementation side, after the procurement, the country will fully implement the price of the bracket after the reduction, the benefits are widespread.
(Reporter Liang Wei Zhang Jianxin)